SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: Ray who wrote (1483)10/13/1998 5:38:00 PM
From: biodoc  Read Replies (2) | Respond to of 2173
 
The NASDAQ was down, many other biotech's were down significantly--this isn't necessarily anything to do with AMLN.



To: Ray who wrote (1483)10/13/1998 8:43:00 PM
From: arnie h  Read Replies (1) | Respond to of 2173
 
Ray: The indicators I follow didn't show anything amiss. The stock continues to be accumulated albeit at a slow pace. Volume on the drop was quite low. All in all, seems like a case of background noise.

No real basis for the price to do much of anything until the European trials results are in.

Arnie


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News